Table 3.
Multivariate analysis of risk factors related to mean CIMT
| Mean CIMT | Females | Males | ||||||
|---|---|---|---|---|---|---|---|---|
| Parameter | OR | p value | 95% CI | OR | p value | 95% CI | ||
| Lower | Upper | Lower | Upper | |||||
| Age | 1.006 | < 0.001* | 1.182 | 2.144 | 1.008 | < 0.001* | 1.006 | 1.011 |
| AOPPs | 0.980 | 0.879 | 0.753 | 1.274 | 1.458 | 0.004* | 1.125 | 1.889 |
| Smoker | 1.041 | 0.136 | 0.987 | 1.098 | 1.036 | 0.191 | 0.982 | 1.093 |
| Hypertension | 1.029 | 0.168 | 0.988 | 1.071 | 0.976 | 0.370 | 0.925 | 1.03 |
| Dyslipidemia | 0.998 | 0.907 | 0.960 | 1.036 | 0.936 | 0.001* | 0.901 | 0.972 |
| Diabetes | 1.014 | 0.656 | 0.952 | 1.081 | 1.035 | 0.293 | 0.971 | 1.104 |
| BMI | 0.999 | 0.371 | 0.996 | 1.002 | 1.005 | 0.079 | 0.999 | 1.01 |
| HDL-C | 0.973 | 0.183 | 0.934 | 1.013 | 1.007 | 0.752 | 0.964 | 1.052 |
| LDL-C | 0.944 | 0.492 | 0.975 | 1.012 | 1.018 | 0.049* | 1.001 | 1.035 |
| HbA1c | 0.944 | 0.257 | 0.953 | 1.036 | 1.032 | 0.079 | 0.996 | 1.069 |
| ARB therapy | 0.956 | 0.257 | 0.885 | 1.033 | 0.967 | 0.164 | 0.922 | 1.015 |
AOPPs, Advanced oxidation protein products; ARB, angiotensin receptor blockers; BMI, body mass index; HbA1c, hemoglobin A1c; HDL-C, high-density lipoprotein cholesterol; *significant values